Phase I Study of Cabazitaxel - Platinum Fluorouracil Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Trial Profile

Phase I Study of Cabazitaxel - Platinum Fluorouracil Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2015

At a glance

  • Drugs Cabazitaxel (Primary) ; Cisplatin; Fluorouracil
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jun 2015 Results of dose escalation phase are presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 09 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 28 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top